Drug Study of Mannitol RMC
Drug Study of Mannitol RMC
Drug Study of Mannitol RMC
MANAGEMNET
BRAND NAME: -Increases the osmotic -adjunct in -contraindicated in: -CNS; -Monitor V/S, Urine
OSMITROL, pressure of the glomerular treatment of: acute 1.hypersensitivity Confusion, output, CVP, And
RASECTISOL filtrate, thereby inhibiting oliguric renal headache. pulmonary artery
reabsorption of water and failure ,edema, 2. Anuria. pressures prior to and
electrolytes. increased -EENT: Blurred hourly throughout
intracranial or 3.Dehydration vision. administration.
-Causes excretion of: H2O, intraocular
NA, K , Mg, CA, P, Chloride, pressure. 4.Active intra cranial -CV- chest pain, -Assess patient for
GENERIC Uria, Uric acid. bleeding. pulmonary edema signs and symptoms
NAME; mannitol -GU irrigant: tachycardia. of dehydration
-Mobilization of excess fluid during transurethral (decreased skin
in oliguric renal failure or procedures (2.5-5% -GI: nausea, turgor, fever,dry skin
edema. solution only) thirst, vomiting. and mucous
membranes, thirst) or
-reduction of intraocular or -GU: renal signs of fluid
intracranial pressure. failure, urinary overload ( increased
retention. CVP, dyspnea,
-increase of urinary excretion rales/crackles, edema.
of toxic materials. -F and
E:dehydration, -Asses patient for
-decreased hemolysis when hyperkalemia, anorexia, muscle
used an irrigant following hypokalemia, weakness, numbness,
tansurethral prostatic hypernatremia, tingling, paresthesia,
resection. hyponatrimia, confusion, and
excessive thirst.
Report signs of
electrolytes
imbalance.